Biological follow-up showed development of secondary hyperparathyroidism (parathyroid hormone (PTH) 539 pg/mL, calcium 1.82 mmol/L, and phosphorus 2.35 mmol/L in December 2013), stabilisation of transaminase levels around three times the upper fold, a decrease of GGT levels (226 UI/L in December 2013), and a steady increase of bilirubin levels (total bilirubin 144 μmol/L, conjugated bilirubin 129 μmol/L in December 2013). Here, PTH is linked to secondary hyperparathyroidism.